NEW YORK (GenomeWeb) – Invitae announced after the close of the market on Monday that its preliminary second quarter revenues grew 157 percent year over year.

Additionally, the company said it had entered into a definitive agreement to sell $73.5 million of its stock in a private placement that will include existing and new investors, and is slated to close around Aug. 3.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.